AB0160 Epigenetic Studies in Maternally versus Paternally Transmitted Psoriatic Disease
Background Epidemiological studies have noted excess paternal transmission in psoriasis and psoriatic arthritis. To date, there has been no molecular explanation to account for this observation. Differential methylation patterns have long been implicated as a potential mechanism to account for exces...
Gespeichert in:
Veröffentlicht in: | Annals of the rheumatic diseases 2014-06, Vol.73 (Suppl 2), p.856-856 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 856 |
---|---|
container_issue | Suppl 2 |
container_start_page | 856 |
container_title | Annals of the rheumatic diseases |
container_volume | 73 |
creator | O'Rielly, D.D. Pollock, R. Zhang, Y. Al-Ghanim, N. Yazdani, R. Hamilton, S. Bricknell, R. Chandran, V. Ardern, R. Gladman, D.D. Zhai, G. Rahman, P. |
description | Background Epidemiological studies have noted excess paternal transmission in psoriasis and psoriatic arthritis. To date, there has been no molecular explanation to account for this observation. Differential methylation patterns have long been implicated as a potential mechanism to account for excess paternal transmission. Objectives In this pilot study, we investigated the differential methylation pattern among paternally and maternally transmitted PsA. Methods Twenty-four (24) patients with maternally transmitted PsA were compared with 24 paternally transmitted PsA cases. For maternally transmitted PsA, the proband's mother had either psoriasis or PsA, and for paternally transmitted PsA, the proband's father had either psoriasis or PsA. Genome-wide DNA methylation profiling was performed on all these 48 samples by using Illumina HumanMethylation450k Beadchip, which measures up ∼480,000 different CpG sites per sample and covers 96% of RefSeq genes. The methylation level at each CpG site was measured by β values varying from 0 (no methylation) to 1 (100% methylation). Results Maternally transmitted PsA cases were predominantly females (19/24) with mean age of onset of PsA at 30.6 years. For paternally transmitted PsA, there were slightly more females (13/24) and age of onset of PsA was 22.2 years. Methylation data were normalized using BMIQ method and no batch effects were detected by PCA analysis. Methylation analysis was performed on 382,024 of the 485,512 CpG sites after filtering and revealed 90 significant CpG sites (p |
doi_str_mv | 10.1136/annrheumdis-2014-eular.3309 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1777971835</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4008701631</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1855-4a4373ff0a01a28186f882450bbf8a79130e2ea149d579e59542da15cc8a4b943</originalsourceid><addsrcrecordid>eNqVkE1Lw0AQhhdRsFb_Q6Dn1N3sbrKLp1o_oWLBevC0TJKJbslH3U2E3rz4R_0lJlbQq6dhXt5nGB5CJoxOGePxKdS1e8Guyq0PI8pEiF0Jbso51XtkxESs-jim-2REKeWh0HFySI68X_crVUyNyNPsnLKYfr5_XG7sM9bY2ix4aLvcog9sHdxBi66GstwGb-h854Plb7JyUPvKti3mwdI3zsJAX1iP4PGYHBRQejz5mWPyeHW5mt-Ei_vr2_lsEaZMSRkKEDzhRUGBMoj6n-JCqUhImqaFgkQzTjFCYELnMtEotRRRDkxmmQKRasHHZLK7u3HNa4e-NeumGx70hiVJohOmuOxbZ7tW5hrvHRZm42wFbmsYNYNL88elGVyab5dmcNnT8Y5Oq_W_wC82l4CW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777971835</pqid></control><display><type>article</type><title>AB0160 Epigenetic Studies in Maternally versus Paternally Transmitted Psoriatic Disease</title><source>BMJ Journals - NESLi2</source><creator>O'Rielly, D.D. ; Pollock, R. ; Zhang, Y. ; Al-Ghanim, N. ; Yazdani, R. ; Hamilton, S. ; Bricknell, R. ; Chandran, V. ; Ardern, R. ; Gladman, D.D. ; Zhai, G. ; Rahman, P.</creator><creatorcontrib>O'Rielly, D.D. ; Pollock, R. ; Zhang, Y. ; Al-Ghanim, N. ; Yazdani, R. ; Hamilton, S. ; Bricknell, R. ; Chandran, V. ; Ardern, R. ; Gladman, D.D. ; Zhai, G. ; Rahman, P.</creatorcontrib><description>Background Epidemiological studies have noted excess paternal transmission in psoriasis and psoriatic arthritis. To date, there has been no molecular explanation to account for this observation. Differential methylation patterns have long been implicated as a potential mechanism to account for excess paternal transmission. Objectives In this pilot study, we investigated the differential methylation pattern among paternally and maternally transmitted PsA. Methods Twenty-four (24) patients with maternally transmitted PsA were compared with 24 paternally transmitted PsA cases. For maternally transmitted PsA, the proband's mother had either psoriasis or PsA, and for paternally transmitted PsA, the proband's father had either psoriasis or PsA. Genome-wide DNA methylation profiling was performed on all these 48 samples by using Illumina HumanMethylation450k Beadchip, which measures up ∼480,000 different CpG sites per sample and covers 96% of RefSeq genes. The methylation level at each CpG site was measured by β values varying from 0 (no methylation) to 1 (100% methylation). Results Maternally transmitted PsA cases were predominantly females (19/24) with mean age of onset of PsA at 30.6 years. For paternally transmitted PsA, there were slightly more females (13/24) and age of onset of PsA was 22.2 years. Methylation data were normalized using BMIQ method and no batch effects were detected by PCA analysis. Methylation analysis was performed on 382,024 of the 485,512 CpG sites after filtering and revealed 90 significant CpG sites (p<0.05). The three most significant CpG sites were hypermethylated regions located on chromosome 8 that did not reside on or adjacent to a gene, with p values ranging from 9x10–7 to 5x10–6. Many genes of interest based on current understanding of psoriatic disease were identified including hypermethylation of CPG sites on MICA (diff 10.22%; p=0.014), IRIF1 (diff 10.3%; p=0.016), PSORS1C3 (diff 11.1%; p=0.005); and TNFS4 (diff 15.2%; 0.004). Excess hypomethylation at CPG sites was noted on PSORS1C1 (18.9% diff. p=0.027). Conclusions These preliminary results demonstrate that the global DNA methylation pattern in paternally transmitted PsA differs from maternally transmitted PsA. High priority candidate regions and genes identified in this study need further validation. Disclosure of Interest None declared DOI 10.1136/annrheumdis-2014-eular.3309</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/annrheumdis-2014-eular.3309</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><ispartof>Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.856-856</ispartof><rights>2014, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2014 (c) 2014, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b1855-4a4373ff0a01a28186f882450bbf8a79130e2ea149d579e59542da15cc8a4b943</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/73/Suppl_2/856.1.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/73/Suppl_2/856.1.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,3196,23571,27924,27925,77600,77631</link.rule.ids></links><search><creatorcontrib>O'Rielly, D.D.</creatorcontrib><creatorcontrib>Pollock, R.</creatorcontrib><creatorcontrib>Zhang, Y.</creatorcontrib><creatorcontrib>Al-Ghanim, N.</creatorcontrib><creatorcontrib>Yazdani, R.</creatorcontrib><creatorcontrib>Hamilton, S.</creatorcontrib><creatorcontrib>Bricknell, R.</creatorcontrib><creatorcontrib>Chandran, V.</creatorcontrib><creatorcontrib>Ardern, R.</creatorcontrib><creatorcontrib>Gladman, D.D.</creatorcontrib><creatorcontrib>Zhai, G.</creatorcontrib><creatorcontrib>Rahman, P.</creatorcontrib><title>AB0160 Epigenetic Studies in Maternally versus Paternally Transmitted Psoriatic Disease</title><title>Annals of the rheumatic diseases</title><description>Background Epidemiological studies have noted excess paternal transmission in psoriasis and psoriatic arthritis. To date, there has been no molecular explanation to account for this observation. Differential methylation patterns have long been implicated as a potential mechanism to account for excess paternal transmission. Objectives In this pilot study, we investigated the differential methylation pattern among paternally and maternally transmitted PsA. Methods Twenty-four (24) patients with maternally transmitted PsA were compared with 24 paternally transmitted PsA cases. For maternally transmitted PsA, the proband's mother had either psoriasis or PsA, and for paternally transmitted PsA, the proband's father had either psoriasis or PsA. Genome-wide DNA methylation profiling was performed on all these 48 samples by using Illumina HumanMethylation450k Beadchip, which measures up ∼480,000 different CpG sites per sample and covers 96% of RefSeq genes. The methylation level at each CpG site was measured by β values varying from 0 (no methylation) to 1 (100% methylation). Results Maternally transmitted PsA cases were predominantly females (19/24) with mean age of onset of PsA at 30.6 years. For paternally transmitted PsA, there were slightly more females (13/24) and age of onset of PsA was 22.2 years. Methylation data were normalized using BMIQ method and no batch effects were detected by PCA analysis. Methylation analysis was performed on 382,024 of the 485,512 CpG sites after filtering and revealed 90 significant CpG sites (p<0.05). The three most significant CpG sites were hypermethylated regions located on chromosome 8 that did not reside on or adjacent to a gene, with p values ranging from 9x10–7 to 5x10–6. Many genes of interest based on current understanding of psoriatic disease were identified including hypermethylation of CPG sites on MICA (diff 10.22%; p=0.014), IRIF1 (diff 10.3%; p=0.016), PSORS1C3 (diff 11.1%; p=0.005); and TNFS4 (diff 15.2%; 0.004). Excess hypomethylation at CPG sites was noted on PSORS1C1 (18.9% diff. p=0.027). Conclusions These preliminary results demonstrate that the global DNA methylation pattern in paternally transmitted PsA differs from maternally transmitted PsA. High priority candidate regions and genes identified in this study need further validation. Disclosure of Interest None declared DOI 10.1136/annrheumdis-2014-eular.3309</description><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqVkE1Lw0AQhhdRsFb_Q6Dn1N3sbrKLp1o_oWLBevC0TJKJbslH3U2E3rz4R_0lJlbQq6dhXt5nGB5CJoxOGePxKdS1e8Guyq0PI8pEiF0Jbso51XtkxESs-jim-2REKeWh0HFySI68X_crVUyNyNPsnLKYfr5_XG7sM9bY2ix4aLvcog9sHdxBi66GstwGb-h854Plb7JyUPvKti3mwdI3zsJAX1iP4PGYHBRQejz5mWPyeHW5mt-Ei_vr2_lsEaZMSRkKEDzhRUGBMoj6n-JCqUhImqaFgkQzTjFCYELnMtEotRRRDkxmmQKRasHHZLK7u3HNa4e-NeumGx70hiVJohOmuOxbZ7tW5hrvHRZm42wFbmsYNYNL88elGVyab5dmcNnT8Y5Oq_W_wC82l4CW</recordid><startdate>201406</startdate><enddate>201406</enddate><creator>O'Rielly, D.D.</creator><creator>Pollock, R.</creator><creator>Zhang, Y.</creator><creator>Al-Ghanim, N.</creator><creator>Yazdani, R.</creator><creator>Hamilton, S.</creator><creator>Bricknell, R.</creator><creator>Chandran, V.</creator><creator>Ardern, R.</creator><creator>Gladman, D.D.</creator><creator>Zhai, G.</creator><creator>Rahman, P.</creator><general>BMJ Publishing Group LTD</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>201406</creationdate><title>AB0160 Epigenetic Studies in Maternally versus Paternally Transmitted Psoriatic Disease</title><author>O'Rielly, D.D. ; Pollock, R. ; Zhang, Y. ; Al-Ghanim, N. ; Yazdani, R. ; Hamilton, S. ; Bricknell, R. ; Chandran, V. ; Ardern, R. ; Gladman, D.D. ; Zhai, G. ; Rahman, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1855-4a4373ff0a01a28186f882450bbf8a79130e2ea149d579e59542da15cc8a4b943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O'Rielly, D.D.</creatorcontrib><creatorcontrib>Pollock, R.</creatorcontrib><creatorcontrib>Zhang, Y.</creatorcontrib><creatorcontrib>Al-Ghanim, N.</creatorcontrib><creatorcontrib>Yazdani, R.</creatorcontrib><creatorcontrib>Hamilton, S.</creatorcontrib><creatorcontrib>Bricknell, R.</creatorcontrib><creatorcontrib>Chandran, V.</creatorcontrib><creatorcontrib>Ardern, R.</creatorcontrib><creatorcontrib>Gladman, D.D.</creatorcontrib><creatorcontrib>Zhai, G.</creatorcontrib><creatorcontrib>Rahman, P.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O'Rielly, D.D.</au><au>Pollock, R.</au><au>Zhang, Y.</au><au>Al-Ghanim, N.</au><au>Yazdani, R.</au><au>Hamilton, S.</au><au>Bricknell, R.</au><au>Chandran, V.</au><au>Ardern, R.</au><au>Gladman, D.D.</au><au>Zhai, G.</au><au>Rahman, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AB0160 Epigenetic Studies in Maternally versus Paternally Transmitted Psoriatic Disease</atitle><jtitle>Annals of the rheumatic diseases</jtitle><date>2014-06</date><risdate>2014</risdate><volume>73</volume><issue>Suppl 2</issue><spage>856</spage><epage>856</epage><pages>856-856</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>Background Epidemiological studies have noted excess paternal transmission in psoriasis and psoriatic arthritis. To date, there has been no molecular explanation to account for this observation. Differential methylation patterns have long been implicated as a potential mechanism to account for excess paternal transmission. Objectives In this pilot study, we investigated the differential methylation pattern among paternally and maternally transmitted PsA. Methods Twenty-four (24) patients with maternally transmitted PsA were compared with 24 paternally transmitted PsA cases. For maternally transmitted PsA, the proband's mother had either psoriasis or PsA, and for paternally transmitted PsA, the proband's father had either psoriasis or PsA. Genome-wide DNA methylation profiling was performed on all these 48 samples by using Illumina HumanMethylation450k Beadchip, which measures up ∼480,000 different CpG sites per sample and covers 96% of RefSeq genes. The methylation level at each CpG site was measured by β values varying from 0 (no methylation) to 1 (100% methylation). Results Maternally transmitted PsA cases were predominantly females (19/24) with mean age of onset of PsA at 30.6 years. For paternally transmitted PsA, there were slightly more females (13/24) and age of onset of PsA was 22.2 years. Methylation data were normalized using BMIQ method and no batch effects were detected by PCA analysis. Methylation analysis was performed on 382,024 of the 485,512 CpG sites after filtering and revealed 90 significant CpG sites (p<0.05). The three most significant CpG sites were hypermethylated regions located on chromosome 8 that did not reside on or adjacent to a gene, with p values ranging from 9x10–7 to 5x10–6. Many genes of interest based on current understanding of psoriatic disease were identified including hypermethylation of CPG sites on MICA (diff 10.22%; p=0.014), IRIF1 (diff 10.3%; p=0.016), PSORS1C3 (diff 11.1%; p=0.005); and TNFS4 (diff 15.2%; 0.004). Excess hypomethylation at CPG sites was noted on PSORS1C1 (18.9% diff. p=0.027). Conclusions These preliminary results demonstrate that the global DNA methylation pattern in paternally transmitted PsA differs from maternally transmitted PsA. High priority candidate regions and genes identified in this study need further validation. Disclosure of Interest None declared DOI 10.1136/annrheumdis-2014-eular.3309</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/annrheumdis-2014-eular.3309</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-4967 |
ispartof | Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.856-856 |
issn | 0003-4967 1468-2060 |
language | eng |
recordid | cdi_proquest_journals_1777971835 |
source | BMJ Journals - NESLi2 |
title | AB0160 Epigenetic Studies in Maternally versus Paternally Transmitted Psoriatic Disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T13%3A18%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AB0160%E2%80%85Epigenetic%20Studies%20in%20Maternally%20versus%20Paternally%20Transmitted%20Psoriatic%20Disease&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=O'Rielly,%20D.D.&rft.date=2014-06&rft.volume=73&rft.issue=Suppl%202&rft.spage=856&rft.epage=856&rft.pages=856-856&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/annrheumdis-2014-eular.3309&rft_dat=%3Cproquest_cross%3E4008701631%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777971835&rft_id=info:pmid/&rfr_iscdi=true |